ArticleScientific reports2025

TRIM39 aggravates hepatocellular carcinoma growth through targeting the p62-KEAP1-NRF2 axis.

Tianbao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.